Skip navigation

Navigate Evolving Global Requirements and Streamline Data Collection and Accuracy

April 2-3, 2019
  • Amsterdam, The Netherlands

CBI’s 9th Annual Global Transparency Reporting Congress provides up-to-date information on regulations and trends in reporting and managing transparency of payments to healthcare providers by bio/pharmaceutical and medical device firms. This conference will offer differing insights for how to achieve a globally compliant culture across the organisation, as well as transform the ethics of the organisation.

Around the World Experts —
Interactive Roundtable Exchanges Devoted to Emerging Markets

Imelda Alvarez
CEO and Founder
Comply Latam S.C. Advisor
FIFARMA

Alondra Diaz
Latin America Regional
Compliance Director
Pfizer

Albert van Maaren
Regional Compliance Officer Healthcare APAC
Merck KGaA

Karolin Dahmer
Compliance Aggregate Spend Analyst
Merz Pharma GmbH
& Co. KGaA

Leading International Associations

Karen Borrer
Head of Corporate Communication
ABPI (Association of the
British Pharmaceutical Industry)

Andrea Pucci
International and Compliance Advisor
Medicines for Europe

Julie Bonhomme
Legal Affairs & Compliance Director
EFPIA – European Federation
of Pharmaceutical Industries
and Associations

TIMELY CONTENT TO STAY UP-TO-DATE:

  • Address the added value of patient organisations reporting
    and transparency
  • Collaborate with peers to measure the impact of transparency
  • Review data collection and data retention processes
  • Identify best practices to ensure completeness of third-party spend, including auditing spend data and underlying processes/systems
  • Understand further integration of transparency processes in adjacent company processes (source to pay, master data management,
    business intelligence standards)
  • Examine lessons learned from U.S. Sunshine Reporting
  • Discuss effective approaches used to monitor the
    evolving privacy environment
  • Learn about common pitfalls of misinterpretation and miscommunication of cross-border requirements

Previous Attendee Acclaim:

Very interesting conference giving you all
the insights to transparency.

Senior Corporate Counsel, Novo Nordisk

This is an interesting opportunity to share best practices and to feel that we are not the
only ones to struggle in our company.

Compliance Transparency Manager, GE Healthcare

Very interesting overview of different approaches
and interpretations. Very educational.

Supplier Evaluation & HCP Transparency Manager, Lundbeck

9th Annual Global Transparency Reporting Congress

Navigate Evolving Global Requirements and Streamline Data Collection and Accuracy

CBI’s 9th Annual Global Transparency Reporting Congress provides up-to-date information on regulations and trends in reporting and managing transparency of payments to healthcare providers by bio/pharmaceutical and medical device firms. This conference will offer differing insights for how to achieve a globally compliant culture across the organisation, as well as transform the ethics of the organisation.

Around the World Experts —
Interactive Roundtable Exchanges Devoted to Emerging Markets

Imelda Alvarez
CEO and Founder
Comply Latam S.C. Advisor
FIFARMA

Alondra Diaz
Latin America Regional
Compliance Director
Pfizer

Albert van Maaren
Regional Compliance Officer Healthcare APAC
Merck KGaA

Karolin Dahmer
Compliance Aggregate Spend Analyst
Merz Pharma GmbH
& Co. KGaA

Leading International Associations

Karen Borrer
Head of Corporate Communication
ABPI (Association of the
British Pharmaceutical Industry)

Andrea Pucci
International and Compliance Advisor
Medicines for Europe

Julie Bonhomme
Legal Affairs & Compliance Director
EFPIA – European Federation
of Pharmaceutical Industries
and Associations

TIMELY CONTENT TO STAY UP-TO-DATE:

  • Address the added value of patient organisations reporting
    and transparency
  • Collaborate with peers to measure the impact of transparency
  • Review data collection and data retention processes
  • Identify best practices to ensure completeness of third-party spend, including auditing spend data and underlying processes/systems
  • Understand further integration of transparency processes in adjacent company processes (source to pay, master data management,
    business intelligence standards)
  • Examine lessons learned from U.S. Sunshine Reporting
  • Discuss effective approaches used to monitor the
    evolving privacy environment
  • Learn about common pitfalls of misinterpretation and miscommunication of cross-border requirements

Previous Attendee Acclaim:

Very interesting conference giving you all
the insights to transparency.

Senior Corporate Counsel, Novo Nordisk

This is an interesting opportunity to share best practices and to feel that we are not the
only ones to struggle in our company.

Compliance Transparency Manager, GE Healthcare

Very interesting overview of different approaches
and interpretations. Very educational.

Supplier Evaluation & HCP Transparency Manager, Lundbeck